Published 10 days ago • loading... • Updated 10 days ago

Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs

Summary by Medscape

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

1 Articles

All

Left

Center

Right

Medscape

Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

10 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated10 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States 10 days ago on Thursday, February 13, 2025.

Sources are mostly out of (0)

Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs

1 Articles

1 Articles

Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs

Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics